-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Isomerase
- Kinase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 68 products in: Biochemicals >> Chemical Type >> Amino Acid
Amino Acid |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Endogenous glycine agonist Purity: > 98% |   | ||
| AMPA agonist Purity: > 99% |   | ||
| AMPA agonist Purity: > 98% | | ||
| Broad spectrum glutamate antagonist Purity: > 99% | | ||
| Selective group III mGlu agonist Purity: > 99% | | ||
| Broad spectrum glutamate antagonist; water soluble Purity: > 99% | | ||
| NMDA glutamate site antagonist Purity: > 99% | | ||
| NMDA glutamate site antagonist Purity: > 99% | | ||
| NMDA glutamate site antagonist. Water soluble form. Purity: > 99% | | ||
| Potent, selective GABAB agonist Purity: > 98% | | ||
| Precursor to nitric oxide synthesis Purity: > 99% | | ||
| Selective GABAB agonist. Active enantiomer. Purity: > 98% | | ||
| GABAB agonist Purity: > 99% | | ||
| GABAB antagonist, brain penetrant | | ||
| Competitive NMDA antagonist Purity: > 99% | | ||
| Competitive NMDA antagonist Purity: > 99% | | ||
| Potent GABAB antagonist Purity: > 99% | | ||
| AMPA / kainate agonist Purity: > 98% | | ||
| Selective mGlu5 agonist Purity: > 98% | | ||
| mGlu5 agonist; water soluble Purity: > 99% | | ||
| Potent NMDA antagonist | | ||
| Potent NMDA antagonist | | ||
| Potent competitive NMDA antagonist Purity: > 98% | | ||
| Potent group II/III metabotropic glutamate receptor antagonist Purity: > 99% | | ||
| mGlu8a agonist Purity: > 99% | | ||
| Ionotropic glutamate antagonist. Low affinity AMPA antagonist. Purity: > 99% | | ||
| Group I mGlu receptor agonist Purity: > 98% | | ||
| Selective group I mGlu agonist Purity: > 99% | | ||
| EAAT2 inhibitor Purity: > 99% | | ||
| Kainate agonist. Neurotoxin. Purity: > 98% | | ||
| Potent, selective AMPA agonist Purity: > 99% | | ||
| Inhibitory neurotransmitter | | ||
| α2δ ligand Purity: > 99% | | ||
| Excitatory neurotransmitter Purity: > 99% | | ||
| Inhibitory neurotransmitter Purity: > 99% | | ||
| Excitotoxic agonist Purity: > 98% | | ||
| GluK1 kainate agonist Purity: > 98% | | ||
| Prototypic kainate receptor agonist. Purity: > 99% | | ||
| Water-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 ( Purity: > 98% | | ||
| Potent, selective group II antagonist. Group III antagonist at higher concentrations. Purity: > 98% | | ||
| Water-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations. Purity: > 98% | | ||
| Group II mGlu agonist. Systemically active. Purity: > 98% | | ||
| mGlu1a antagonist Purity: > 99% | | ||
| Group II mGlu agonist. Systemically active. Purity: > 99% | | ||
| Group I /II metabotropic glutamate antagonist Purity: > 99% | | ||
| Group I / II mGlu antagonist Purity: > 98% | | ||
| Group I /II metabotropic glutamate antagonist; water soluble Purity: > 99% | | ||
| NOS inhibitor Purity: > 99% | | ||
| GABA reuptake inhibitor Purity: > 98% | | ||
| NOS inhibitor Purity: > 98% | | ||
| AMPA / kainate agonist Purity: > 98% | | ||
| Excitotoxic amino acid Purity: > 98% | | ||
| Ionotropic receptor antagonist Purity: > 98% | | ||
| GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist Purity: > 98% | | ||
| Group I mGlu agonist. AMPA agonist. Purity: > 99% | | ||
| Novel, non-nucleoside DNA methyltransferase inhibitor Purity: > 99% | | ||
| Novel caged-GABA compound, uncaged by visible light | | ||
| Novel caged-glutamate compound, uncaged by visible light | | ||
| GABAB antagonist Purity: > 99% | | ||
| Endogenous NMDA receptor co-agonist Purity: > 98% | | ||
| Highly selective GAT-1 inhibitor Purity: > 99% | | ||
| Highly potent GABAB agonist Purity: > 98% | | ||
| GluN2D (formerly NR2D) antagonist, with some subunit selectivity Purity: > 98% | | ||
| Potent, selective GluK1 (fomerly GLUK5) receptor antagonist Purity: > 98% | | ||
| Inactive isomer of the GluK1 (fomerly GLUK5) receptor antagonist UBP304 Purity: > 98% | | ||
| GluK1 and GluK3 selective antagonist Purity: > 98% | | ||
| Irreversible inhibitor of GABA transaminase Purity: > 98% | | ||
| AMPA / kainate receptor agonist Purity: > 98% | |